+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience



Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience



Circulation 105(16): 1887-1889



Background: Thromboembolism due to atrial fibrillation (AF) is a frequent cause of stroke. More than 90% of thrombi in AF form in the left atrial appendage (LAA). Obliteration of the appendage may prevent embolic complications. Methods and Results: We evaluated the feasibility and safety of implanting a novel device for percutaneous left atrial appendage transcatheter occlusion (PLAATO). LAA occlusion using the PLAATO system was attempted in 15 patients with chronic AF at high risk for stroke, who are poor candidates for long-term warfarin therapy. The implant consists of a self-expanding nitinol cage covered with a polymeric membrane (ePTFE). The LAA was successfully occluded in 15/15 patients (100%). Angiography and transesophageal echocardiography (TEE) during the procedure showed that the device was well-seated in all patients and that there was no evidence of perforation, device embolization, or interference with surrounding structures. In 1 patient, the first procedure was complicated by a hemopericardium, which occurred during LAA access. A second attempt 30 days later was successful with no untoward sequela. No other complications occurred. At 1-month follow-up, chest fluoroscopy and TEE revealed continued stable implant position with smooth atrial-facing surface and no evidence of thrombus. Conclusions: Thus, transcatheter closure of the LAA is feasible in humans. This novel implant technology may be appropriate for patients with AF who are not suitable candidates for anticoagulation therapy. Further trials are needed to show the long-term safety and its efficacy in reducing stroke.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011128711

Download citation: RISBibTeXText

PMID: 11997272

DOI: 10.1161/01.cir.0000015698.54752.6d


Related references

Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in patients with atrial fibrillation First human experience. Journal of the American College of Cardiology 39(5 Suppl. A): 6A, 2002

Percutaneous Left Atrial Appendage Transcatheter Occlusion (Plaato System) to Prevent Stroke in High-Risk Patients With Non-rheumatic Atrial Fibrillation: Results From the International Multi-Center Feasibility Trials. Yearbook of Cardiology 2006: 416-417, 2006

Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. Journal of the American College of Cardiology 46(1): 9-14, 2005

Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to Prevent Stroke in High-Risk Patients With Non-rheumatic Atrial Fibrillation: Results From the International Multi-Center Feasibility Trials. Yearbook of Medicine 2006: 365-366, 2006

Novel device for percutaneous left atrial appendage transcatheter occlusion to prevent stroke in patients with atrial fibrillation. European Heart Journal 23(Abstract Suppl.): 498, August-September, 2002

Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in patients with atrial fibrillation Initial results of the multicenter feasibility trial. Journal of the American College of Cardiology 41(6 Suppl. A): 79A, 2003

Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in patients with atrial fibrillation Interim results of the multicenter feasibility trial. Journal of the American College of Cardiology 43(5 Suppl. A): 33A, 2004

Percutaneous left atrial appendage transcatheter occlusion in patients with chronic nonvalvular atrial fibrillation: early institutional experience. Journal of Cardiovascular Medicine 7(8): 569-572, 2006

Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. Jacc. Cardiovascular Interventions 2(7): 594-600, 2009

Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke. Catheterization and Cardiovascular Interventions 83(4): 664-669, 2014

TCT-724 Efficacy of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Journal of the American College of Cardiology 66(15): B295-B296, 2015

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion. Europace 16(5): 626-630, 2014

Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clinical Research in Cardiology 105(3): 225-229, 2016

Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke. Journal of Interventional Cardiac Electrophysiology 33(1): 69-75, 2012

Transcatheter closure of left atrial appendage with the Amplatzer Cardiac Plug in patients with atrial fibrillation and high risk of thromboembolic events--early experience. Kardiologia Polska 68(2): 250-254, 2010